Skip to main content

Harmful effects of maternal use of antileptic drugs on the fetus/newborn and its long term effect



Epilepsy in a pregnant women:
Of all pregnant women, 0.3%-0.8% are affected with epilepsy which makes it the most common neurological disorder that needs a medical treatment during pregnancy. [1] Most women with epilepsy will need antiepileptic drugs (AEDs) throughout their pregnancy to control their seizures. [2] Therefore, use of AEDs raises concern related to the harmful effects on fetus while in her womb (teratogenicity) and afterwards (during its subsequent extra-uterine existence as a neonate and infant). 
Harmful effects on fetus and neonates: [3]
There is an increased risk in offspring of women with epilepsy exposed to the antiepileptic drugs, of structural and neurodevelopmental effects including, intrauterine growth retardation, cognitive dysfunction, microcephaly, both major and minor malformations (4-6%) and even infant mortality. [4] Infants exposed to antiseizure drugs in utero who are born with congenital malformations are termed to have fetal anticonvulsant syndrome. 

Major congenital malformations:
1.       Neural tube (spina bifida aperta, open lumbosacral myelocele)
2.   Congenital heart (ASD, VSD, PDA, PS, TOF) and urinary tract defects (glandular hypospadias) [3, 4]
3.       Skeletal abnormalities and cleft palate

Minor congenital malformations: 
1.       hypoplasia of the nails and distal phalanges
2.       hypertelorism
3.       the "anticonvulsant face" including
-          broad or depressed nasal bridge
-          short nose with anteverted nostrils
-          long upper lip

Individual antiepileptic drugs contributing in the congenital malformations:
·   Valproate: Neural-tube like defects (spina bifida aperta, open lumbosacral myelocele), meningomyelocele, cardiovascular, and urogenital malformations and craniofacial, skeletal, and genital anomalies. First trimester maternal exposure to valproic acid (VPA) increases the risk of major malformations, independent of any contribution of the epilepsy syndrome itself.

·         Phenytoin:  Orofacial clefts, cardiac malformations, and genitourinary defects

·         PhenobarbitalMalformations of the heart, orofacial, and urogenital structures

·         Carbamazepine: Associated with major malformations such as spina bifida.

·         Topiramate: oral clefts in infants

Long terms effects of antiepileptic drugs:
AEDs may have deleterious effects on the cognitive and neurologic function of the offspring that may manifest later in life. Valproate is the most strongly associated with adverse cognitive and developmental outcomes and it also increases the risk of autism spectrum disorders in children.

Mechanism for antiseizure drug-induced teratogenicity:
1.       Low or deficient epoxide hydrolase activity that results in increased levels of teratogenic oxidative metabolites.
2.       Oxidative damage to DNA from free radical intermediates produced by prostaglandin H synthase bioactivation of antiseizure drugs
3.       Deficiency of folic acid associated with antiseizure drugs (which are folic acid antagonists)
     Note: Mechanism for antiseizure drug-induced teratogenicity has not been determined and these are possible mechnisms underlies the teratogenicity.
 References:

Comments

Popular posts from this blog

Consent Forms

Hindi BMJ Consent form   Bengali BMJ Consent form English BMJ Consent form   Telegu BMJ Consent Form Telegu BMJ Consent Form   UDHC Consent Form                

55 years Old male with Bipolar affected disorder moving from depression to Manic to depression phase

Disclaimer:- This is a HIPAA de-identified open-online-patient-record with initial information in patient's voice, posted here December 2017 after collecting informed patient consent (form downloadable Click Here) This is a case of a 55 years old, diabetic, hypertensive patient who was diagnosed with Bipolar affected disorder since 1995. In 1995 due to financial loss he was attacked by this condition. He was seen by Dr. D. K Agarwala and diagnosed as BPAD-Depression phase and treated with lithium, sodium valporate, propranolol, Zeptol cr, Nitrosum - S.  With the treatment he was reasonably well but every 6 months of interval he appeared to have some disturbance like didn't want to talk to anybody, forgot to smile etc. They went to the doctor and treated accordingly and was continuing the treatment.  In the year of 2013, August he was diagnosed with BPAD-severe depression phase but, he was not responding well to the medications and then they went to NIMHANS for

60 year old woman with hypothyroidism and SIADH

This patient is a 60 year old woman with recent vomiting, coma (sodium 107) and clinical features of dull apathy, skin coarsening, bradycardia, areflexia strongly suggesting hypothyroidism. Serum osmolality and urine sodium are suggesting SIADH. Thyroid profile: Our patient's current dose of sodium is 10ml per hour and she is having mild hypotension at times and in her blood sugar recordings hypoglycemia (attached below) was noted. In brain imaging, empty Sella is noted (attached below).  Most of the data we have till now is suggesting hypopituitarism Online Discussion: